These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli. Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593 [TBL] [Abstract][Full Text] [Related]
66. Control of Type III Secretion System Effector/Chaperone Ratio Fosters Pathogen Adaptation to Host-Adherent Lifestyle. Elbaz N; Socol Y; Katsowich N; Rosenshine I mBio; 2019 Sep; 10(5):. PubMed ID: 31530678 [TBL] [Abstract][Full Text] [Related]
71. Effect of coiled-coil peptides on the function of the type III secretion system-dependent activity of enterohemorragic Escherichia coli O157:H7 and Citrobacter rodentium. Larzábal M; Zotta E; Ibarra C; Rabinovitz BC; Vilte DA; Mercado EC; Cataldi Á Int J Med Microbiol; 2013 Jan; 303(1):9-15. PubMed ID: 23312797 [TBL] [Abstract][Full Text] [Related]
72. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence. Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331 [TBL] [Abstract][Full Text] [Related]
73. Distinct Molecular Features of NleG Type 3 Secreted Effectors Allow for Different Roles during Citrobacter rodentium Infection in Mice. Popov G; Fiebig-Comyn A; Syriste L; Little DJ; Skarina T; Stogios PJ; Birstonas S; Coombes BK; Savchenko A Infect Immun; 2023 Jan; 91(1):e0050522. PubMed ID: 36511702 [TBL] [Abstract][Full Text] [Related]
74. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Hemrajani C; Marches O; Wiles S; Girard F; Dennis A; Dziva F; Best A; Phillips AD; Berger CN; Mousnier A; Crepin VF; Kruidenier L; Woodward MJ; Stevens MP; La Ragione RM; MacDonald TT; Frankel G Infect Immun; 2008 Nov; 76(11):4804-13. PubMed ID: 18725419 [TBL] [Abstract][Full Text] [Related]
75. Phosphotyrosine-Mediated Regulation of Enterohemorrhagic Robertson CD; Hazen TH; Kaper JB; Rasko DA; Hansen AM mBio; 2018 Feb; 9(1):. PubMed ID: 29487233 [TBL] [Abstract][Full Text] [Related]
76. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA. Yen H; Ooka T; Iguchi A; Hayashi T; Sugimoto N; Tobe T PLoS Pathog; 2010 Dec; 6(12):e1001231. PubMed ID: 21187904 [TBL] [Abstract][Full Text] [Related]
77. Characterization of the NleF effector protein from attaching and effacing bacterial pathogens. Echtenkamp F; Deng W; Wickham ME; Vazquez A; Puente JL; Thanabalasuriar A; Gruenheid S; Finlay BB; Hardwidge PR FEMS Microbiol Lett; 2008 Apr; 281(1):98-107. PubMed ID: 18279332 [TBL] [Abstract][Full Text] [Related]
78. Assay for Type III Secretion in Escherichia coli. Mitrovic B; Sal-Man N Methods Mol Biol; 2022; 2427():37-46. PubMed ID: 35619023 [TBL] [Abstract][Full Text] [Related]
79. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector. Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469 [TBL] [Abstract][Full Text] [Related]
80. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection. Serapio-Palacios A; Finlay BB Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]